A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Clinical trial NCT00717457 · COMPLETED
Trial details
- NCT number
- NCT00717457
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2011-03-01
- Enrollment
- 1189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.